Safety and efficacy of first-line bevacizumab-based therapy in advanced non-squamous non-small-cell lung cancer (SAiL, MO19390): a phase 4 study by Crinò, Lucio, Prof, Dansin, Eric, MD, Garrido, Pilar, MD, Griesinger, Frank, Prof, Laskin, Janessa, MD, Pavlakis, Nick, MBBS, Stroiakovski, Daniel, Prof, Thatcher, Nick, Prof, Tsai, Chun-Ming, Prof, Wu, Yi-long, Prof, Zhou, Caicun, Prof

Get full text